chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt is in with left arm pain. She said she used to get some cramps or charley horse occasionally somewhere in her hand between the third and fourth digits kind of "like toe cramps". Subsequently she got more cramps the day of the shot and then started developing an allusive pain in the anterior shoulder across the pectoral region and anterior deltoid and then down the arm into the radial forearm and into the hand. The pain migrates a little bit worse with use. It dose not keep her from sleeping at night. She notes that her hand is somewhat weaker and it has been progressively getting worse for the last 2 weeks. She has not had any neck pain. Denies any loss of sensation. No color change. No temperature change or coldness or circulatory symptoms. She received the Gardasil on 04-06-07 left deltoid. 2 months ago she was Indian wrestling and somewhat wrenched her neck a little bit and had some minor discomfort and when she extends her head she has a little bit of pain or discomfort at the base of her neck. No history of neck pain. No history of cervical disk problems, any other injury, or trauma to the left upper extremity. No other neurologic symptoms. No fevers. No URI symptoms, respiratory complaints, no cough, wheezy, dyspnea, no cardiac complaints. No abdominal pain, diarrhea or vomiting. No urinary frequency, dysuria or change, No gross weight change or any constitutional symptoms. No swelling of the extremities. No skin rashes or unusual markings.
Menstruation started 3 - 8 days later than normal and bleeding is more profuse. The only other side effect was soreness in the arm where the shot was injected that lasted for a few days.
COVID-19 outbreak March 2021. The symptoms were a general feeling of not being well, tired, headache, mild nausea, and a headache at times with general fatigue. I called my doctor's office and I spoke to a nurse and described what was going on and they prescribed Paxlovid, and I have been taking that. The illness lasted about 4 days. I am feeling fine now and outcome is good.
I had my vaccination on 09/30/2022. In 10/06/2022 I went for a follow up to dermatologist the hair follicles at hair line were looking strange. I was diagnosed with Alopecia.  I was prescribed Doxycycline a topical steroid and Rogaine. I went for a follow up in 12/31/2022 and the hair line was looking better in regard to hair loss. I am referred to a different specialist that will do a biopsy on the hair follicles.
NSTEMI with acute CHF. monitored troponin and gave lasix to help remove fluid
Erythema, pain, and swelling (size of a quarter) at the site of injection: Started 04/28/2021 afternoon - Still occurring
the first day it was sore arm only. by the first night, it was chills, night sweats, body aches which lead to insomnia and when able to sleep, nightmares (i normally don't remember my dreams), headache (felt like a sinus headache, but even my hair follicles on my head were sore because i could not even tolerate my hair in a bun, which i normally wear every day in the summer, loss of appetite, major fatigue. the intensity diminished as the days went by. i was too weak to work and still taking vitamin c with zinc, a multivitamin with extra b5 and niacin and eventually ibuprofen by day 5, which helped most; it just hate taking medication and would prefer that my body heal on its own; it wasn't. also an energy shot it took with oj, lemon juice, ginger root, oil of oregano, cayenne pepper and elderberry provided some temporary relief.
This spontaneous report was received from a 53 year old male consumer, reporting on himself. The patient's medical history included vertigo and depression. Concomitant therapies included citalopram (CITALOPRAM). The patient had no pertinent drug reactions/allergies. On 10-AUG-2017 the patient was vaccinated with ZOSTAVAX 19400 Plaque Forming Units (PFU), subcutaneously for prevention of herpes zoster (dose, units or lot number were not reported). On approximately 17-AUG-2017, about a week after onset of therapy the patient experienced shortness of breath, tightness in upper left side of chest, and a sensitivity to milk products. No treatment was given for the adverse events. On 07-SEP-2017 the patient had a doctor appointment where an Electrocardiogram (EKG) and vital sign test were performed (the results were not provided). The outcome for shortness of breath, tightness in upper left side of chest, and sensitivity to milk products was reported as not recovered. Causality assessment was not provided.
Information has been received from an RN concerning a pt who was vaccinated with 1 dose of pneumococcal vaccine 23 polyvalent. Within the first day, post vax, the pt experienced injection site induration that was "band-like", local redness and soreness that increased with severity, peaking within 48-64 hours. On approximately 10/9/99, the pt experienced extreme swelling, pain and discomfort that is still ongoing. On 10/11/99, the pt was seen by a physician who prescribed Claritin. The reporter expressed a concern with the lot number. Additional information has been requested.
Chills, fever, tiredness, rash on face, cold sweats, heart rate dropping to 53 bpm, warm, cold, headache, body aches.
With in a few minutes of receiving the injection patient said he felt like he was going to faint.  HCP stood next to patient and he remained upright in the chair but his head rolled back, he became pale and sweaty and passed out.  Patient recovered and 10 minutes later repeated the episode.  Patient recovered and 5 or 10 minutes later he repeated the episode.  BP was 90/50, 89/53 and 109/76.  He received 25mg of benedryl.  An ambulance transported him to the hospital for further observation.
Booster instead of third dose in immunocompromised; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (Booster instead of third dose in immunocompromised) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Aug-2021, the patient experienced ACCIDENTAL UNDERDOSE (Booster instead of third dose in immunocompromised) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 22-Aug-2021, ACCIDENTAL UNDERDOSE (Booster instead of third dose in immunocompromised) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2022, Antibody test: negative (Negative) Negative- Patient did not have any antibody protection..         No concomitant medication were reported.  No treatment information were provided.  Her rheumatologist had suggested that she should proceed with receiving the fourth dose.
Reports "memory issues" the next day that lasted 2 hours. Reports he felt better the next. Will f/u with PCP.
rash, bumps and itching on neck and chest on right side of body. muscle sore in area of administration. warm to touch. Advised patient  representative to inform PCP of reaction prior to receiving 2nd dose. Tried to contact patient, left voice messages, no response to obtain further information for reporting and to check on current condition.
shingles after the vaccine / suspected vaccination failure; shingles; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by patient friend. The age at vaccination was not reported. The reporter stated that the patient suffered with shingles after taking the Shingles vaccine, why there were class action lawsuits, but we did not want to talk about that part. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. This case had been linked with US2021AMR174908, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR174908:same reporter
had headache, fever, and a temperature that went from 96 and then 100. She said she felt cold and hot; had headache, fever, and a temperature that went from 96 and then 100. She said she felt cold and hot; had headache, fever, and a temperature that went from 96 and then 100. She said she felt cold and hot; severe intestinal cramps, diaarrhea, sweats, and severe shaking that is almost close to convulsive shaking, muscle aches in her torso, and lower back near the kidney area; severe intestinal cramps, diarrhea, sweats, and severe shaking that is almost close to convulsive shaking, muscle aches in her torso, and lower back near the kidney area; severe intestinal cramps, diarrhea, sweats, and severe shaking that is almost close to convulsive shaking, muscle aches in her torso, and lower back near the kidney area; severe intestinal cramps, diarrhea, sweats, and severe shaking that is almost close to convulsive shaking, muscle aches in her torso, and lower back near the kidney area; severe intestinal cramps, diarrhea, sweats, and severe shaking that is almost close to convulsive shaking, muscle aches in her torso, and lower back near the kidney area; This is a spontaneous report from a non-contactable female consumer reported for herself. A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: unknown, expiry date: unknown), via an unspecified route of administration on Jan2021 as 1st dose, single dose for Covid-19 immunization.Patient medical history and concomitant medications were not reported. In Jan2021 the patient experienced severe reactions. These reactions include severe intestinal cramps, diarrhea, sweats, and severe shaking that was almost close to convulsive shaking, muscle aches in her torso, and lower back near the kidney area. She also said she had headache, fever, and a temperature that went from 96 and then 100. She said she felt cold and hot. Patient underwent lab test and procedure body temperature was 96 and then 100 degrees Celsius in Jan2021. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a health professional concerning a 29 year old female who on 16Feb04 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently the pt experienced arm sensitivity, swelling of the arm and a large red area about 5cm. Unspecified medical attention was sought. No product quality complaint was involved. Another pt had the same experience after the vaccination with pneumococcal 23v polysaccharide vaccine. Additional information has been requested.
Infant was NOT immunized directly, but her mother was via injection in the left shoulder. Infant eats primarily breastmilk. About 24 hours after the vaccine was administered, infant began to exhibit signs of discomfort, fussiness, and low fever (100.5 F). Infant woke up 3 times at night crying and apparently experiencing pain. Infant exhibited reduced symptoms following administration of oral liquid Tylenol. Red rash comprised of small bumps and skin discoloration was observed 4 days after vaccine was administered, though infant does not appear to scratch or react to the rash.
The day after getting the vaccine I started having an intermittent tremor in my lower lip. This has continued through 12/29/20.
Information has been received from a health professional concerning a 7 year old female patient who on 06/06/2000 was vaccinated with a dose of varicella virus vaccine live.  Subsequently, on approximately 04/26/2004, the patient developed breakthrough chickenpox with less than 50 lesions.  Follow up information indicated that there was not a single report of adverse reaction following varicella vaccination.  The reporter indicated that 49 other patients developed breakthrough cases of chickenpox.  No additional information is expected.
Office drew up all vaccines from vial at the beginning of the day and discarded vial. They put the bivalent NDC, lot and expiration on a sticky note and entered all data into the EMR from that sticky note. After a few weeks they realized that some days they had pulled monovalent vial and administered instead of bivalent booster as intended. It is impossible to discern which patient received which vaccine.
Patient received FLUAD vaccine and 5 minutes later began having symptoms consistent with panic attack. He reported having a rapid heart rate and had abdominal spasm/cramping. His abdominal symptoms were both visible and palpable on examination. I did vitals only (BP 225/90, Heart Rate 155, RR 19) and had pharmacy technician call EMS. Within 2 to 3 minutes his symptoms subsided and he stated that he felt much better. Vitals on recheck were as follows: BP 160/85, HR 80, RR 15. Patient had no respiratory distress and showed no signs of anaphylaxis. EMS came and checked him out and said everything was normal (ECG and vitals). EMS suspected that it may have been a panic attack, though the patient felt it might be a reaction to the FLUAD vaccine.
Information has been received from a pharmacist referring to three unspecified patients of unknown age and gender. There was no information about the patients' medical history and concurrent condition. On unknown dates, the patients were vaccinated with the same lot number of PNEUMOVAX 23 (lot # L008664; Expiration date: 03-NOV-2016; strength, dose and route unknown) in the thigh (it was unknown if the vaccine was administered in the right or left thigh). The concomitant therapy was not provided. On unknown dates, all the three patients experienced redness at the injection site and injection site reactions in general. At the time of the report, the outcome of the adverse events were unknown. The reporting pharmacist requested a lot check on this lot # of PNEUMOVAX 23. Additional information has been requested.
Pt devel high fever, chills & vomiting 1hr p/being immunized;
Pneumovax admin 7/13/04 on 7/15/04 developed s/s 2 days after injection. Following with rash, redness, soreness axilla. Dx: probable cellulitis. Tx: Keflex 250mg 1 cap every 6 hours x 5 days
This spontaneous report was received from a pharmacist and refers to a 86 year old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unspecified date, the patient was to receive an unspecified injection for an unspecified coexisting condition which may caused shingles. On 09-JAN-2017, the patient was vaccinated with an expired dose of ZOSTAVAX lot # L006392, expiration date 25-MAY-2016. No adverse effects were reported. Additional information has been requested.
@ approx 8PM devel swelling of  face & both arms;c/o pain in head, chest & abd;taken to ER & was told allerg rxn;tx w/DPH;
Large (3-4 inch) red, raised welt at the injection site. The welt was also very hot. The welt stayed for 1-2 days after the vaccination. Other minor side effects included extreme fatigue 1-2 days following vaccination.
Flu vac given 10/6/10 (L) deltoid by LPN pt back to clinic 10/25/10 with c/o pain in shoulder (L) 11/12/10 pain cont & seen number of times / MRI on 12/10/10.
he had a fever of 102 that rose to 103.5F; He also has muscle aches; This is a spontaneous report from a contactable consumer (patient's fiance). A 42-year-old male patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration yesterday (08May2021) at 14:00 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received dose 1 of BNT162B2 on an unspecified date and experienced similar symptoms but not as severe. On 09May2021 at 02:00, the patient experienced a fever of 102 that rose to 103.5 degrees Fahrenheit (F). He also had muscle aches. The patient was treated with paracetamol (TYLENOL). The outcomes of fever and muscle aches were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Starting a few days after the vaccine 2nd dose, I felt very fatigued and tired and getting headaches. As time when on, I was getting pain in my chest and SOB and having to use my asthma inhalers. The inhalers were not really helping improve my breathing. I did a Dr. visit and was put on prednisone, which did not help. I made another appt for in person visit with my doctor. They did a COVID test and I am still waiting the results. My oxygen is good and my lungs look good. I was prescribed antibiotics Levaquin. I am only on day 1 of Levaquin.
lumps on neck; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lumps on neck) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Jan-2021, the patient experienced LYMPHADENOPATHY (lumps on neck). On 22-Jan-2021, LYMPHADENOPATHY (lumps on neck) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Laboratory test: unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-073434 (Patient Link).
Sore at left deltoid, hives arms, legs, body given BENADRYL 25mg PO at 1245 & TYLENOL 320mg PO (80#girl) hives resolved. Parents called. Here at 2 pm meds - PCN for strep. throat.
suspected Vaccination failure; got the shingles really bad; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's parent. The age at vaccination was not reported. The patient got vaccinated and got the shingles really bad. The reporter guess if it was in your make up you get them no matter what. This case considered as suspected vaccination failure since the details regarding time to onset, dose number and laboratory confirmation regarding shingles were not reported.
Hypotensive episode - pallor & unresponsiveness 4 hrs after 1st set of immun on 2/5/09 - labs normal, BP low, fine after.
SWOLLEN MOUTH AND CHEEKS; INCREASED NOCTURNAL URINATION; This spontaneous report received from a patient concerned a 77 year old male. The patient's height, and weight were not reported. The patient's past medical history included: prostate surgery. On an unspecified date, the patient received covid-19 vaccine ad26. cov2. s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, for prophylactic vaccination (manufacturer not specified).  On 25-OCT-2021, the patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1872811, and expiry: UNKNOWN) dose was not reported, for prophylactic vaccination. No concomitant medications were reported.  On 25-OCT-2021, the patient experienced swollen mouth and cheeks at night. On 25-OCT-2021, the patient experienced possible increased nocturnal urination, but is not sure if that is associated with the vaccine since he has had prostate surgery. The swelling began subsiding throughout Tuesday, and continued to decrease till 27-OCT-2021, but not yet fully resolved. The swelling was mainly in the jowls area.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from swollen mouth and cheeks, and the outcome of increased nocturnal urination was not reported. This report was non-serious.
1 of 4 pts who exp an inject site react @ the DTP site only, approx 6 hrs p/immun; reaction consisted of swelling, redness, hot to touch & myalgia; treated w/advil;